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Abstract
Background: The Gambia has one of the lowest survival rates for breast cancer in Africa. Contributing factors are
late presentation, delays within the healthcare system, and decreased availability of resources. We aimed to
characterize the capacity and geographic location of healthcare facilities in the country and calculate the
proportion of the population with access to breast cancer care.
Methods: A facility-based assessment tool was administered to secondary and tertiary healthcare facilities and
private medical centers and clinics in The Gambia. GPS coordinates were obtained, and proximity of service
availability and population analysis were performed. Distance thresholds of 10, 20, and 45 km were chosen to
determine access to screening, pathologic diagnosis, and surgical management. An additional population analysis
was performed to observe the potential impact of targeted development of resources for breast cancer care.
Results: All 102 secondary and tertiary healthcare facilities and private medical centers and clinics in The Gambia
were included. Breast cancer screening is mainly performed through clinical breast examination and is available in
52 facilities. Seven facilities provide pathologic diagnosis and surgical management of breast cancer. The proportion
of the Gambian population with access to screening, pathologic diagnosis, and surgical management is 72, 53, and
62%, respectively. A hypothetical targeted expansion of resources would increase the covered population to 95, 62,
and 84%.
Conclusions: Almost half of the Gambian population does not have access to pathologic diagnosis and surgical
management of breast cancer within the distance threshold utilized in the study. Mapping and population analysis
can identify areas for targeted development of resources to increase access to breast cancer care.
Keywords: Breast cancer, Access to cancer care, Geospatial analysis, Global health, Global surgery, Sub-Saharan
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Background
As sub-Saharan Africa (SSA) suffers from a growing bur-
den of non-communicable diseases, cancer is being rec-
ognized as an emerging public health concern that
requires attention. (1–3) Across SSA, the incidence of
breast cancer is increasing, and in The Gambia incidence
is increasing the most in women younger than 50 years
of age, with up to 71% of cases diagnosed in this age
group. (4–6) In 1986, the Gambia National Cancer
Registry became one of the few nationwide population
based cancer registries in SSA. (6) Current data from
this registry, which is the data source for the Globocan
2020 estimates identifies breast cancer as the second
most common cancer in women. (2)
A diagnosis of breast cancer in SSA often portends a
poor prognosis, in part due to the 77% of black women
in SSA who present with advanced disease. (7) The
Gambia is estimated to have one of the lowest 5-year
age-standardized relative survival rates for cancer com-
pared to other African, Asian, and Central American
countries. (8) Delayed diagnosis is one reason for ad-
vanced disease. Women in SSA wait about 3–6 months
between noticing a symptom and presenting for care,
and additional delays of 3–6 months occur between
presentation and diagnosis. (9) Limited knowledge about
breast cancer, misconceptions about the cause and avail-
able treatments, and socio-cultural factors all contribute
to delayed presentation in SSA. (10) The second delay
experienced, between presentation and diagnosis, reflects
inefficiencies and gaps in care within the health system.
Currently in The Gambia, it is not well defined
where breast cancer services are offered. The current
healthcare system consists of three major tiers. (11)
“Tertiary health care facilities”, which provide the
highest level of care, are composed of private clinics,
general hospitals and a single teaching hospital. Sec-
ondary health facilities, also called “Basic health ser-
vices” include district hospitals, major health centers,
and minor health centers. District hospitals are the
highest functioning within this tier, but expected ser-
vices are not well defined. Major health centers pro-
vide some minor surgeries, laboratory, and radiology
services. Minor health centers focus on basic obstetric
and child health services. “Village health services”
focus on primary care and tend to minor injuries and
illnesses. Understanding where breast cancer care is
available within these tiers and where gaps in care
exist is an important step in further developing the
healthcare system to manage breast cancer. In this
study, we aim to accurately delineate the locations
and specific capacity of secondary and tertiary health
facilities in The Gambia to screen, diagnose, and treat
breast cancer and document population density sur-
rounding each facility.
Methods
Study design and population
A cross-sectional, facility based survey was conducted in
The Gambia from March 9, 2020 to April 9, 2020. A
comprehensive list of secondary and tertiary health facil-
ities and private medical centers and clinics was ob-
tained from the regional health directorates. Village
health services were not included in the study since
these facilities are not expected to provide breast cancer
care.
Survey design
We developed a survey tool to assess the screening, diag-
nosis, and treatment services available for breast cancer
at health facilities in The Gambia (Supplementary ma-
terial). The structure was based on two existing surveys
that are used to assess surgical capacity: The World
Health Organization’s “Tool for Situational Analysis to
Assess Emergency and Essential Surgical Care,” (WHO
Tool) and Surgeons OverSeas’s (SOS) “Personnel, Infra-
structure, Procedures, Equipment, and Supplies Tool”
(PIPES Tool). (12, 13) The WHO Tool was the first situ-
ational analysis tool widely used to assess surgical ser-
vices worldwide and has been used in over 45 low- and
middle-income countries. (14) The PIPES Tool was de-
veloped as a modification to the WHO tool, but absolute
numbers of personnel, hospital beds, and operating
rooms were added and other questions were stream-
lined. (13) In their current form, neither tool was con-
sidered sufficient to assess breast cancer care capacity, as
this involves multidisciplinary care that extends beyond
surgery. For this reason, we developed a tool specific to
breast cancer services utilizing the overall structure of
the WHO and PIPES tools, including sections to inquire
about human resources, infrastructure, procedures and
surgeries performed, and equipment available as an out-
line. Local and international experts involved in breast
cancer care then reviewed the tool and provided feed-
back. First, general information was obtained for each fa-
cility, including facility type, ownership, and whether or
not the facility conducts exclusive breast clinics or sees
patients with breast conditions in general clinics. Avail-
able service capacity was then assessed for each of the
following topics: personnel, imaging, screening methods,
diagnosis capacity, procedures and treatments per-
formed, and follow-up.
The section on personnel assessed the number of
people involved in breast cancer care in each facility.
Medical doctors, physician assistants (PA), and other
support staff including technicians, social workers, and
nurses were included. The availability of resources and
services was categorized as follows: 1) always available
(resource/service available > 80% of the time over the
last year), 2) not always available (resource/service
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available ≤80% of the time over the last year), and 3)
Not available (resource/service not available at the
facility).
Survey administration
Seven research assistants (RAs), one from each of the
seven health regions, were trained on the objectives of
the survey, ethics, use of global positioning system
(GPS), systematic and protocol-based surveying tech-
nique, and consistency in data entry. The survey tool
was used in Western Region 2 (WR2) as the pilot study
area. In this pilot phase, two respondents were inter-
viewed separately per facility, each by a group of two
RAs to assess consistency in survey administration. RAs
were trained to use their mobile phones to obtain GPS
locations of participating facilities. Location settings on
their mobile phones were set to high accuracy. GIS coor-
dinates were obtained via the native Maps app before
entering the building to enhance accuracy. After com-
pletion of the pilot, RAs travelled to their assigned re-
gion for nationwide delivery.
Print and electronic copies of the tool were distributed
by RAs prior to arrival at the facilities, allowing the re-
spondents time to become familiar with the survey. Each
facility identified the most suitable and knowledgeable
employee to answer questions. The RAs ensured the re-
spondent had reviewed the questionnaire and scheduled
a date for the interview. GPS coordinates of the facilities
were collected by the RA at the time of survey
administration.
Hospital stratification and data analysis
Descriptive data analysis was performed and results pre-
sented as frequency and proportions. Analysis was per-
formed using Stata software (version 14.0, 2015). The
National Comprehensive Cancer Network (NCCN)
Framework for Resource Stratification of NCCN Guide-
lines, which provides recommendations for cancer care
pathways based on available resources, was used as a
guideline to develop a stratification system. The goal of
the stratification was to objectively assess available re-
sources for breast cancer care in The Gambia. (15)
NCCN’s guidelines include three tiers: “Basic,” “Core,”
and “Enhanced,” which for simplicity we labeled Level 3,
2, and 1 respectively (Table 1). (16–21) In order to bet-
ter differentiate facilities that are unable to provide the
full spectrum of care as described by the NCCN, we cre-
ated three additional levels as follows: Level 6- facilities
that provide screening and clinical diagnosis, Level 5- fa-
cilities that provide screening, clinical diagnosis, and
pathologic diagnosis, and Level 4- facilities that provide
screening, clinical diagnosis, pathologic diagnosis, and
surgery (Table 1). Hospitals that did not fulfill the
criteria for any of the mentioned levels were labelled as
“other.”
Mapping, proximity analysis, reasonable travel distance,
and targeted resource allocation
GIS (Geographic Information Systems) technology was
employed to derive the proximity of service availability
and population served within specified distances. Facility
locations were geospatially visualized utilizing ArcGIS
Pro software (Environmental Systems Research Institute
2020, Version 2.6), and proximity buffers extending out-
ward in 5 km (km) increments were generated. By in-
corporating a 2018 LandScan population density raster
obtained from the Oak Ridge National Laboratory (Oak
Ridge, TN, USA), which depicts the dispersal of individ-
uals throughout the region, a zonal statistics tool was
deployed to obtain population numbers contained within
each of the 5 km proximity buffers. (22) An analysis
using driving distance was first attempted, but this was
very limited and our GIS expert (JS) was concerned it
was potentially inaccurate due to the sparse roads and
barriers data available in the region. Due to this, an ana-
lysis with Euclidean (straight line) distance was per-
formed as it has been shown to have a reasonable
correlation with driving distance. (23) Patients living
within a prespecified distance from the hospital were
categorized as covered for that service. The results of
the spatial analysis returned values for populations
served within each of the specified distances while pre-
senting a visual representation of the data.
Distance thresholds of 10 km, 20 km, and 45 km were
chosen as reasonable distances for screening, pathologic
diagnosis, and surgical management respectively. There
are no well established thresholds for these services, so
we based our distances on previously published studies
that evaluated the impact of distance on utilization of
health services in SSA. We also discussed reasonable
travel distance with authors who have personal know-
ledge on transportation in The Gambia. Ten kilometers
was identified as a distance predictive for utilization of
screening lab services in a West African study, (24) so
this was chosen as our screening distance threshold. A
South African study noted that patients who had to
travel greater than 20 km for care were more likely to
have advanced breast cancer at diagnosis, so 20 km was
chosen as our diagnosis threshold. (25) Lastly, for surgi-
cal management, a Ghanaian study identified that as
travel time approached 1 hour, more than 80% of re-
spondents would rarely or irregularly utilize available
health services. (26) We chose 45 km as the surgical
treatment threshold in an attempt to keep the associated
travel time less than 1 h in most instances.
To observe the potential impact of a hypothetical tar-
geted resource allocation to increase diagnosis and
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surgical management services, two Level 6 facilities were
selected. These facilities were selected because 1) their
geographic location would maximize the cumulative area
of coverage with minimal overlap and 2) their staff already
includes MD surgeons who could potentially be trained to
provide surgical care for breast cancer. Additional maps
were created and a spatial analysis was performed with
these two facilities modeled as Level 4 facilities.
Ethical approval
Ethical review was sought from the joint committee of
Research and Publication Committee University of The
Table 1 Criteria for stratification of healthcare facilities
Health Facility Stratification
LEVEL 1 (NCCN Enhanced) LEVEL 2 (NCCN Core) LEVEL 4
Screening and clinical diagnosis Screening and clinical diagnosis Screening and clinical diagnosis
-Clinical breast examination
-Mammography
-Clinical breast examination -Clinical breast examination
Pathologic confirmation & Imaging Pathologic confirmation & Imaging Pathologic confirmation & Imaging
-Core needle biopsy
-Skin punch biopsy
-Pathological review (in house or external)
-ER/PR status testing (in house or external)








-Genetic counseling and genetic testing
-Core needle biopsy
-Pathological review (in house or external)




-Excisional biopsy, incisional biopsy, core needle biopsy, or fine needle
aspiration cytology
-Pathological review (in house or external)
-Ultrasound
-X Ray




-Sentinel lymph node biopsy
-Breast reconstruction





-Sentinel lymph node biopsy
-Oophorectomy (or medical ovarian
suppression)
-Mastectomy (always or sometimes available)a
-Axillary dissection (always or sometimes available)a










-Long term surveillance/follow up
-Supportive/palliative care
LEVEL 3 (NCCN Basic) LEVEL 5
Screening and clinical diagnosis Screening and clinical diagnosis
-Clinical breast examination -Clinical breast examination
Pathologic confirmation & Imaging Pathologic confirmation & Imaging
-Excisional biopsy or incisional biopsy
-Pathological review (in house or external)




-Excisional biopsy, incisional biopsy, core needle biopsy, or fine needle
aspiration cytology
-Pathological review (in house or external)
-Ultrasound
Surgical treatment LEVEL 6
-Mastectomy
-Axillary dissection
-Oophorectomy (or medical ovarian
suppression)




-Long term surveillance/follow up
-Supportive/palliative care
Table 1 Detailed list of services required to be categorized under each health facility level. A health facility must have ALL listed services to be categorized under
a specific level. These services must be available > 80% of the time throughout the year unless otherwise specified. Level 6 represents a hospital with the fewest
breast cancer services
a“Sometimes available” includes hospitals that reported offering a service, but it is only available < 80% of the time throughout the year
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Gambia (UTG) and Medical Research Council (MRC)
Ethics committees. As this was a facility based survey
with no patient involvement and no protected health in-
formation required, informed consent was given by the
institution and signed by the institution’s respondent.
Results
One hundred and two health facilities were surveyed in-
cluding: the single teaching hospital in the country,
seven general hospitals, four district hospitals, three
major health centers, 56 minor health centers, and 31
medical centers/clinics. Fifty-nine of the facilities were
owned by the state, 29 were privately owned, six were
owned by faith-based organizations, four were quasi-
government (i.e. community-managed facilities with par-
tial government funding) and four responded as “other”
(including three facilities managed by Non-
governmental organizations and one facility funded by
international institutions but primarily managed by The
Gambian government). Response rate of our survey was
100%, which was accomplished because of coordination
with the regional health directorates, who supported the
research project and encouraged involvement from the
facilities. Twenty-four reported they routinely provide
breast cancer care, and the teaching hospital reported
having a dedicated breast clinic.
Thirty-six health facilities, including the teaching hos-
pital, were located in WR1, an urban region where the
capital city of Banjul is located. All health regions had at
least one district or general hospital, and several minor
health centers. The seven health regions are further di-
vided into 42 health districts. Five of these health dis-
tricts did not have a single health facility. These health
districts were located in WR2, URR, and CRR. (Table 2).
A total number of 191 healthcare workers providing
breast cancer care were reported across the 102 health
facilities. Of note, 126 (66%) of these workers are in
WR1. Midwives formed the largest category, with 69
employed across the country. Every region except NBE
had a trained midwife providing services in breast cancer
care. Twenty-two (22) medical doctor (MD) surgeons
were reported in the country: 19 in WR1, two in CRR,
and one in NBE. The other four regions did not have a
surgeon. CRR also had three PA surgeons. There were
Table 2 Health facilities in The Gambia
Health Facilities in The Gambia
Health Region
Name
Population of Health Region (%
of total population)
Number of Health Districts
within Region






888,336 (40.4%) 3 36
- 1 teaching hospital
- 3 general hospitals
- 1 major health center
- 10 minor health centers




460,953 (21%) 8 14
- 1 general hospital
- 1 district hospital
- 1 major health center
- 7 minor health centers




269,704 (12.3%) 7 13
- 1 district hospital
- 1 major health center
- 9 minor health centers




246,652 (11.2%) 11 12
- 1 general hospital




86,022 (3.9%) 6 11
- 1 district hospital
- 6 minor health centers




123,623 (5.6%) 4 9
- 2 general hospitals




124,164 (5.6%) 3 7
- 1 district hospital
- 6 minor health centers
5.63
Total 2,199,454 (100%) 42 102 4.63
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19 radiology personnel in the country: 11 technicians,
five specialists, and three consultants located in only
three regions, WR1, CRR, and NBE. The single plastic
surgeon, pathology specialist, and pathology consultant
in the country were all located in WR1. There were no
reported medical oncology or radiation oncology
personnel in the country. Sixty-seven “other” personnel
included clinical residents, medical officers, house offi-
cers, and other general practitioners and nurses that
were not included as a separate category in our survey.
Breast cancer screening is mainly performed via clin-
ical breast examination (CBE), and this was always avail-
able at 52 of the 102 health facilities. Only one
mammogram machine was functioning in the country
and was located in a private medical center in WR1.
Ultrasound was available in 11 facilities: eight in WR1,
and one each in the NBE, CRR, and LRR regions. X-ray
was available in 11 facilities, eight in WR1, and one each
in the WR2, CRR, and NBE regions. The three com-
puted tomography (CT) scanners and the single mag-
netic resonance imaging (MRI) machine in the country
were all located in WR1. Positron emission tomography
(PET) scans were not available.
For the pathologic diagnosis of breast cancer, seven fa-
cilities performed fine needle aspiration and excisional
biopsy. Five of these facilities also performed core needle
biopsy. Only one facility had in house pathology services
and the other six used an external lab. All facilities offer-
ing services for pathologic diagnosis were located in
WR1. Immunohistochemistry to test for estrogen recep-
tor (ER), progesterone receptor (PR), and human epider-
mal growth factor receptor 2 (HER2) status was not
available in The Gambia.
Seven hospitals, all located in WR1, provided surgery
for the treatment of breast cancer offering both mastec-
tomy and wide local excision. Six of the seven facilities
reported performing axillary surgery, but no facilities
perform sentinel lymph node biopsy. Three facilities, all
in WR1, offer cyclophosphamide, methotrexate, fluoro-
uracil (CMF) for chemotherapy, and one of these facil-
ities also has paclitaxel and cisplatin. Breast
reconstruction, radiotherapy, and endocrine therapy
were not available in The Gambia. Palliative care was
available at eight facilities in WR1, and one facility in
WR2, CRR, LRR, NBE, and NBW.
When the facility level stratification was applied, seven
were classified as Level 4 and 38 were classified as Level
6 (Fig. 1). The majority of facilities providing breast can-
cer care were located in WR1 (Table 3). No facilities
could provide the full spectrum of care detailed in the
NCCN Framework Guidelines. The five facilities that
offer the most services are all located in WR1 and are all
categorized as Level 4 facilities. Three of the facilities re-
quire the addition of mammography, endocrine therapy,
and testing for ER/PR status in order to provide Level 3
care. The fourth facility would require the addition of
core needle biopsy, endocrine therapy, and testing for
ER/PR status to provide Level 3 care.
The spatial analysis found that 72% of The Gambian
population lives within 10 km of breast cancer screening
with CBE, 53% lives within 20 km of pathologic diagno-
sis services, and 62% lives within 45 km of basic surgical
care (Fig. 2). If all facilities that do not provide CBE
started offering this service, 94% of the population would
be within 10 km of basic screening services (Fig. 3A). If
the two hospitals identified for a hypothetical targeted
resource allocation as detailed above started offering
diagnostic and surgical management services, the pro-
portion of The Gambian population with geographic ac-
cess to diagnosis and surgical services would increase to
62% (from 53%) and 84% (from 62%), respectively (Fig.
3B, C).
Discussion
Improving breast cancer outcomes in a resource limited
setting is challenging. Ensuring adequate geographic ac-
cess to screening, early diagnosis, and treatment options
is a critical step forward in improving breast cancer out-
comes. In The Gambia, breast cancer care is often frag-
mented across different health facilities separated by
wide geographical distances. With the 5 year age stan-
dardized survival for a woman with breast cancer in The
Gambia being only 12%, (8) optimization of care path-
ways and access should be prioritized. Our study accom-
plished a comprehensive analysis of available services for
breast cancer care and identified geographical areas most
in need of expanded resources.
In this study, 38 facilities were identified that provide
CBE-based screening and clinical diagnosis for symp-
tomatic patients. Seven hospitals (all in WR1) provide
pathologic diagnosis and surgical management. Limited
chemotherapy is available at three facilities (all in WR1),
and endocrine therapy and radiotherapy are not available
in the country. We recognize that screening, pathologic
diagnosis, and surgical care alone still falls short of offer-
ing the level of comprehensive breast cancer care that
optimizes breast cancer outcomes in non-resource lim-
ited countries. However, given the limited resources cur-
rently available in The Gambia, the geospatial analysis
focused on screening, pathologic diagnosis, and surgical
care which are available and offered.
Longer distances to diagnostic and treatment facilities
have been associated with delayed diagnosis and late
stage at diagnosis in SSA. (27) Our results show that
some patients have to travel up to 35 km for screening
services, and up to 300 km for a pathologic diagnosis
and surgery. This limited geographic access to care
could be contributing to the current state of breast
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cancer in The Gambia consisting of late presentation
and poor survival. (7, 8) Access to care can most simply
be measured based on the presence of healthcare facil-
ities and services in a health region, with an underlying
assumption that the population of the region has access
to services offered within the regional boundaries. Using
this approach, the results of our survey suggest the pro-
portion of the population with access to screening,
diagnosis, and surgical treatment is 100, 40, and 40%, re-
spectively. The 40% reflects the population in WR1 as
this is the only region with diagnostic and treatment fa-
cilities in the country. Distribution of healthcare finances
in The Gambia also follows this regional approach. The
Directorate for Regional Health allocates finances based
on reports from each region’s administrator that detail
needs within the boundaries of their individual health
Fig. 1 Location of healthcare facilities and level of breast cancer care provided in each facility
Table 3 Stratification of hospitals in The Gambia
Stratification of Hospitals in The Gambia
WR1 WR2 URR CRR LRR NBE NBW Total
Level 1 (NCCN Enhanced) No Facilities 0
Level 2 (NCCN Core) No Facilities 0
Level 3 (NCCN Basic) No Facilities 0
Level 4 (screening + path + surgery) 7 0 0 0 0 0 0 7
Level 5 (screening + path) No Facilities 0
Level 6 (screening) 20 1 8 4 3 1 1 38
Other* 9 13 5 8 8 8 6 57
*“Other” includes those facilities that did not fulfill criteria for any of the Levels of breast cancer care
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region. Due to the small geographic size and struc-
ture of The Gambia however, expanding care ser-
vices such as pathologic diagnosis and surgery in
each health region may not result in the ideal distri-
bution of resources for the country as a whole. A re-
gional focus does not ensure access to everyone for
services that have a low distance threshold, such as
screening, and would result in an overlap of re-
sources that patients are likely to travel farther for,
such as surgery.
This study provides an alternative approach for re-
source allocation. Because Gambians are able to receive
healthcare in any region, we leveraged GIS data to esti-
mate the proportion of the population living within a
pre-specified distance of healthcare facilities, rather than
based on regional boundaries. Our analysis showed that
current facilities provide screening, diagnosis, and surgi-
cal management to 72, 53, and 62% of the population,
respectively within 10 km, 20 km, and 45 km distance
thresholds. The regional approach overestimates access
Fig. 2 Distance from centers providing A) screening, B) diagnosis, and C) surgical management services for breast cancer currently
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to screening services and underestimates access to diag-
nosis and surgical management. Another commonly
used method to assess accessibility is the density of facil-
ities per population. Using this metric, the density in
each region ranges from 3.03 to 12.78 facilities per
100,000 population. The density observed in WR1 (4.05)
is the second lowest in the country, which is inconsistent
with the fact that its population has the greatest number
of breast cancer services available in their region. Thus,
public health policies and financial allocations based on
these oversimplified estimates could result in overlook-
ing the need for screening services in some regions and
overspending to increase diagnosis and surgical manage-
ment capacity in others. Our mapping could potentially
guide the Ministry of Health to a more geographically
equitable distribution of services while being cognizant
Fig. 3 Distance from centers providing A) screening, B) diagnosis, and C) surgical management services for breast cancer after a hypothesized
targeted resource allocation
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of the constrained resources available. Additionally, this
information can also be used by international partners
to inform their funding.
In order to concisely define the resources available at
each facility and therefore identify gaps in care, we de-
veloped a six level stratification system for the healthcare
facilities. Although the NCCN “Framework” guidelines
were not developed as a stratification system, their tiered
structure provides an intuitive framework to classify hos-
pitals and identify where varying resources are available.
Due to the limited services currently available in The
Gambia, the addition of three levels at the lower-end of
the resource spectrum allowed us to highlight services
available at all facilities. Recommendations regarding re-
source allocation can then be made using this stratifica-
tion system as a guide in order to invest in the services
needed to approach guideline-concordant care.
We identified two investments that could improve
geographic access to screening, diagnostic, and surgical
services across the country. First, in regards to screening,
our survey identified that CBE was predominantly per-
formed by midwives in facilities without medical doc-
tors. Given that midwives were present in almost all
health regions, screening and clinical diagnosis of symp-
tomatic patients could be enhanced if midwives trained
in CBE are employed at all health facilities. This would
require employment of 40 CBE-trained midwives at 40
facilities that do not offer this service, as well as provid-
ing CBE training at the remaining 30 facilities that
already employ midwives. These action steps would en-
able all facilities to provide screening services (Level 6),
meaning that 95% of the population would be able to re-
ceive CBE within a 10 km radius (up from 75%). Second,
in regards to pathologic diagnosis and surgical capacity,
we identified two facilities that already employ surgeons
where expansion of services would result in the greatest
number of Gambians obtaining geographic access to
care. This would require training of surgeons to perform
breast biopsies and breast cancer surgery. Similar to
other Level 4 facilities, pathology review of biopsied
specimens could be obtained through collaboration with
the teaching hospital. After this hypothetical targeted de-
velopment, our population analysis suggests that a sig-
nificant increase in pathologic diagnosis (53 to 62%) and
surgical care (62 to 84%) could be attained.
There are a number of limitations to this study. First,
barriers to accessing care consist of several dimensions
and only two were assessed in this study: availability of
resources and distance from care. There are many other
potential barriers to accessing breast cancer care that
were not evaluated, including healthcare literacy, prefer-
ence for culturally aligned care, costs, road infrastruc-
ture, and travel time. (10, 28, 29) Even though these
barriers were not measured, the most likely effect is that
our study overestimated access, underscoring the im-
portance of the problem. Second, Euclidean distance
(straight-line) was used to estimate distance, and this ap-
proach does not account for road infrastructure. A drive
time analysis would have provided a more accurate
measurement of access to care as shown in previous
studies. (30, 31) However due to insufficient data pub-
licly available for this analysis, our GIS expert recom-
mended using a Euclidean distance model as an
alternative method. While Euclidean distance has dem-
onstrated reasonable correlation with driving time, it
tends to overestimate absolute population access. (23)
This is an important consideration as it could lead to
misclassification when using access thresholds. Third,
there is no consensus on a distance threshold after
which a patient can be considered as having no geo-
graphic access to care. Although we based our thresh-
olds on the best available evidence for distance and
access to healthcare in SSA, these distances are some-
what arbitrary. Finally, our survey tool has not been vali-
dated but it is based on surveys that have been widely
used and previously published.
Conclusions
In conclusion, this study provides a comprehensive as-
sessment of available breast cancer services in The
Gambia and demonstrated the use of geospatial analysis
to identify gaps in care. Although comprehensive breast
cancer care is not currently available in The Gambia,
our stratification system was able to describe distinct
levels of care currently offered. Our mapping and popu-
lation analysis provides information that can be lever-
aged by key stakeholders to maximize return on
investment in healthcare and facilitate collaborations
with The Gambian Ministry of Health. Through targeted
development of resources, a greater proportion of the
population should have geographic access to care, which
could translate to earlier diagnosis and improved
outcomes.
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